MedPath

Treatment of migraine through Unani regimens

Phase 2
Conditions
Health Condition 1: G430- Migraine without aura
Registration Number
CTRI/2020/06/025893
Lead Sponsor
Central Council for Research in Unani Medicine New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A. At least five attacks fulfilling criteria Bâ??D.

B. Headache attacks lasting 4 - 72 hours (untreated or unsuccessfully treated).

C. Headache has at least two of the following four characteristics:

1. Unilateral location

2. Pulsating quality

3. Moderate or severe pain intensity

4. Aggravation by or causing avoidance of routine physical activity (e.g. walking or climbing stairs).

D. During headache at least one of the following:

1. Nausea and/ or vomiting.

2. Photophobia and/ or phonophobia.

E. Not better accounted for by another ICHD 3 diagnosis.

Exclusion Criteria

1. Marked depression, anxiety, psychosis, epilepsy.

2. Pregnancy and lactation.

3. Major medical illness under treatment.

4. Patients with diseases requiring long term treatment.

5. Use of any other alternative medication during study period.

6. History of alcohol and drug abuse.

7. Diabetes mellitus since the test drug i.e. Itrifal Sanai contains sugar.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Headache frequency and headache intensityTimepoint: 0, 7th, 15th, 30th day
Secondary Outcome Measures
NameTimeMethod
Serum C-reactive protein and Apolipoprotein ETimepoint: 0 day and 30th day
© Copyright 2025. All Rights Reserved by MedPath